162 related articles for article (PubMed ID: 8369353)
1. Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid.
Hutchison AJ; Merchant M; Boulton HF; Hinchcliffe R; Gokal R
Perit Dial Int; 1993; 13(3):219-23. PubMed ID: 8369353
[TBL] [Abstract][Full Text] [Related]
2. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Brandi L; Nielsen PK; Bro S; Daugaard H; Olgaard K
J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum ionized magnesium in CAPD patients.
Saha HH; Harmoinen AP; Pasternack AI
Perit Dial Int; 1997; 17(4):347-52. PubMed ID: 9284461
[TBL] [Abstract][Full Text] [Related]
5. Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/L calcium dialysate.
Banalagay EE; Bernardini J; Piraino B
Adv Perit Dial; 1993; 9():271-3. PubMed ID: 8105941
[TBL] [Abstract][Full Text] [Related]
6. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942
[TBL] [Abstract][Full Text] [Related]
7. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
Weinreich T; Ritz E; Passlick-Deetjen J
Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
[TBL] [Abstract][Full Text] [Related]
8. Calcium and magnesium flux in automated peritoneal dialysis.
Eddington H; Hurst H; Ramli MT; Speake M; Hutchison AJ
Perit Dial Int; 2009; 29(5):536-41. PubMed ID: 19776047
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate.
Cho MS; Lee KS; Lee YK; Ma SK; Ko JH; Kim SW; Kim NH; Choi KC
Korean J Intern Med; 2002 Jun; 17(2):114-21. PubMed ID: 12164088
[TBL] [Abstract][Full Text] [Related]
10. Transperitoneal calcium mass transfer using dialysate with a low calcium concentration (1.0 mM).
Weinreich T; Colombi A; Echterhoff HH; Mielke G; Nebel M; Ziegelmayer C; Passlick-Deetjen J
Perit Dial Int; 1993; 13 Suppl 2():S467-70. PubMed ID: 8399641
[TBL] [Abstract][Full Text] [Related]
11. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
Piraino B; Bernardini J; Holley J; Johnston JR; Perlmutter JA; Martis L
Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
[TBL] [Abstract][Full Text] [Related]
12. An amino acid-based peritoneal dialysis fluid buffered with bicarbonate versus glucose/bicarbonate and glucose/lactate solutions: an intraindividual randomized study.
Plum J; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Perit Dial Int; 1999; 19(5):418-28. PubMed ID: 11379854
[TBL] [Abstract][Full Text] [Related]
13. Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations.
Simonsen O; Venturoli D; Wieslander A; Carlsson O; Rippe B
Kidney Int; 2003 Jul; 64(1):208-15. PubMed ID: 12787411
[TBL] [Abstract][Full Text] [Related]
14. Magnesium homeostasis in patients undergoing continuous ambulatory peritoneal dialysis: role of the dialysate magnesium concentration.
Katopodis KP; Koliousi EL; Andrikos EK; Pappas MV; Elisaf MS; Siamopoulos KC
Artif Organs; 2003 Sep; 27(9):853-7. PubMed ID: 12940910
[TBL] [Abstract][Full Text] [Related]
15. Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patients.
Bender FH; Bernardini J; Piraino B
Am J Kidney Dis; 1992 Oct; 20(4):367-71. PubMed ID: 1415205
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations.
Hutchison AJ; Were AJ; Boulton HF; Mawer EB; Laing I; Gokal R
Nephron; 1996; 72(1):52-8. PubMed ID: 8903861
[TBL] [Abstract][Full Text] [Related]
17. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
18. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution.
Ejaz AA; McShane AP; Gandhi VC; Leehey DJ; Ing TS
Perit Dial Int; 1995; 15(1):61-4. PubMed ID: 7734563
[TBL] [Abstract][Full Text] [Related]
19. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
Weinreich T; Passlick-Deetjen J; Ritz E
Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
[TBL] [Abstract][Full Text] [Related]
20. Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients.
Pagliari B; Baretta A; De Cristofaro V; Samà F; Cantaluppi A; Martis L; Imbasciati E
Perit Dial Int; 1991; 11(4):326-9. PubMed ID: 1751598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
